Status: current, Defined. Date: 31-Jan 2015. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2951831000168119 | Arzerra (ofatumumab 100 mg / 5 mL) injection, 3 x 5 mL vials (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2951841000168111 | Arzerra 100 mg/5 mL injection, 3 x 5 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Arzerra 100 mg/5 mL injection, 3 x 5 mL vials | Is a | trade product pack | true | Inferred relationship | Some | ||
| Arzerra 100 mg/5 mL injection, 3 x 5 mL vials | Is a | ofatumumab 100 mg/5 mL injection, 3 x 5 mL vials | true | Inferred relationship | Some | ||
| Arzerra 100 mg/5 mL injection, 3 x 5 mL vials | has TPUU | Arzerra 100 mg/5 mL injection, 5 mL vial | true | Inferred relationship | Some | 1 | |
| Arzerra 100 mg/5 mL injection, 3 x 5 mL vials | has TP | Arzerra | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Arzerra 100 mg/5 mL injection, 3 x 5 mL vials | Is a | True | Arzerra 100 mg/5 mL injection, 3 x 5 mL vials | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR